The healthcare landscape for blood sugar is changing, and GLP-1 patches represent a promising development. Unlike shots, this technique offers a less invasive way to provide GLP-1 therapies. These transdermal systems steadily release the drug through the epidermis offering a even level of the therapeutic agent, which can optimize blood sugar levels